Ulobetasol propionate: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Ulobetasol | {{Short description|Overview of Ulobetasol propionate}} | ||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Ulobetasol_propionate.svg | |||
| image_size = 200px | |||
| image_alt = Chemical structure of Ulobetasol propionate | |||
| image_caption = Chemical structure of Ulobetasol propionate | |||
}} | |||
'''Ulobetasol propionate''' is a [[corticosteroid]] used in the treatment of various skin conditions. It is | '''Ulobetasol propionate''' is a [[corticosteroid]] used in the treatment of various skin conditions. It is known for its potent anti-inflammatory properties and is often prescribed for short-term management of [[dermatological]] disorders. | ||
== | ==Pharmacology== | ||
Ulobetasol propionate is | Ulobetasol propionate is a [[topical]] corticosteroid that works by reducing inflammation and suppressing the immune response in the skin. It is classified as a super-high potency corticosteroid, making it effective for severe skin conditions that do not respond to less potent treatments. | ||
== Mechanism of Action == | ===Mechanism of Action=== | ||
The mechanism of action of ulobetasol propionate involves the induction of [[lipocortin]], which inhibits [[phospholipase A2]]. This action reduces the release of [[arachidonic acid]], a precursor of [[prostaglandins]] and [[leukotrienes]], which are mediators of inflammation. | |||
== | ==Clinical Uses== | ||
Ulobetasol propionate is primarily used for the treatment of [[psoriasis]], [[eczema]], and other inflammatory skin conditions. It is typically applied as a cream or ointment and is intended for short-term use due to its potency. | |||
== | ===Application=== | ||
The medication is applied to the affected area of the skin, usually once or twice daily. It is important to follow the prescribed dosage and duration to minimize the risk of side effects. | |||
== | ==Side Effects== | ||
Common side effects of ulobetasol propionate include skin irritation, dryness, and [[hypopigmentation]]. Prolonged use can lead to more serious side effects such as [[skin atrophy]], [[telangiectasia]], and [[adrenal suppression]]. | |||
== Related | ==Precautions== | ||
Patients using ulobetasol propionate should be monitored for signs of [[HPA axis suppression]], especially if used over large surface areas or for extended periods. It is not recommended for use in children or on the face, groin, or underarms unless directed by a healthcare provider. | |||
==Related pages== | |||
* [[Corticosteroid]] | * [[Corticosteroid]] | ||
* [[Psoriasis]] | * [[Psoriasis]] | ||
* [[Eczema]] | * [[Eczema]] | ||
* [[Topical medication]] | |||
* | |||
[[Category:Corticosteroids]] | [[Category:Corticosteroids]] | ||
[[Category:Dermatologic drugs]] | [[Category:Dermatologic drugs]] | ||
Revision as of 05:27, 16 February 2025
Overview of Ulobetasol propionate
| Ulobetasol propionate | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Ulobetasol propionate is a corticosteroid used in the treatment of various skin conditions. It is known for its potent anti-inflammatory properties and is often prescribed for short-term management of dermatological disorders.
Pharmacology
Ulobetasol propionate is a topical corticosteroid that works by reducing inflammation and suppressing the immune response in the skin. It is classified as a super-high potency corticosteroid, making it effective for severe skin conditions that do not respond to less potent treatments.
Mechanism of Action
The mechanism of action of ulobetasol propionate involves the induction of lipocortin, which inhibits phospholipase A2. This action reduces the release of arachidonic acid, a precursor of prostaglandins and leukotrienes, which are mediators of inflammation.
Clinical Uses
Ulobetasol propionate is primarily used for the treatment of psoriasis, eczema, and other inflammatory skin conditions. It is typically applied as a cream or ointment and is intended for short-term use due to its potency.
Application
The medication is applied to the affected area of the skin, usually once or twice daily. It is important to follow the prescribed dosage and duration to minimize the risk of side effects.
Side Effects
Common side effects of ulobetasol propionate include skin irritation, dryness, and hypopigmentation. Prolonged use can lead to more serious side effects such as skin atrophy, telangiectasia, and adrenal suppression.
Precautions
Patients using ulobetasol propionate should be monitored for signs of HPA axis suppression, especially if used over large surface areas or for extended periods. It is not recommended for use in children or on the face, groin, or underarms unless directed by a healthcare provider.